CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Utilities and disutilities for attributes of injectable treatments for type 2 diabetes
Author
A Gafni
A Zambanini
+74Â more
AHP Paes
AJ Palmer
AJ Rush
AJ Scheen
Andrew C. Palsgrove
Aodan Tynan
B Kartman
BT Srinivasan
C Bradley
C Green
CJ Dunn
D Kim
DA Revicki
DH Feeny
Diabetes Control Complications Trial (DCCT) Research Group
DJ Drucker
DK Arulmozhi
E Warren
EB Bass
EF Juniper
GW Torrance
GW Torrance
GW Torrance
GW Torrance
H Linnebjerg
H Zhou
HOE 901/2004 Study Investigators Group
Hoffmann-La Roche Ltd
I McDowell
I Ohsawa
J Albu
J Cohen
J Cook
J Rex
JH Anderson Jr
JH Anderson Jr
JL Gonzalez
JS Garrow
K Blumenschein
K Howorka
K Johnston
K Secnik
K Stavem
K Stein
Kate Van Brunt
Kimberly N. Walter
Kristina S. Boye
L Shi
LN Jorgensen
Louis S. Matza
LS Matza
LS Matza
M Koopmanschap
MA Nauck
MF Drummond
MP Rutten-van Molken
N Chokrungvaranon
P McEwan
PF Stalmeier
PM Clarke
RE Pratley
RG Bretzel
RL Kolotkin
RL Kolotkin
RN Greenberg
RT Anderson
S Heller
S Schwartz
SD Sullivan
SG Ashwell
T Richardson
T Vilsboll
UK Prospective Diabetes Study (UKPDS) Group
W Shen
Publication venue
Publication date
Field of study
No full text
Utilities, Type 2 diabetes, Injection, Dose frequency, Patient preference, Standard gamble, I00, I10, I19,
Crossref
Research Papers in Economics